In The News

Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO

As the White House attempts to expand overdose treatment, Ensysce is planning to provide pain relief with overdose protection.

Ensysce Biosciences: A Solution to the Opioid Crisis?

As We Enter “the Most Dangerous Time of the Year”, a Solution to Prescription Opioid Overdose may be in Sight

Dr. Vince Clinical Research Announces Dosing of Ensysce's PF614 Compound in Human Abuse Potential Trial

Women in Pharma: Ensysce Biosciences’ CEO aims to combat prescription drug abuse

Ensysce Featured on Benzinga All Access

Ensysce Biosciences’ transformative chemistry targeting drug safety and performance

Thought Leader, Dr. Lynn Kirkpatrick Discusses a New Class of Prescription Drugs Designed to Defeat Abuse & Overdose